Mimics and chameleons in motor neurone disease

Practical Neurology

Volumn 13, Issue 3, 2013, Pages 153-164

  Turner, Martin R ^a   Talbot, Kevin ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DELAYED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HUMAN; MOTOR NEURON DISEASE; PATHOPHYSIOLOGY; REVIEW;

MOTOR NEURON DISEASE;

DELAYED DIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HUMANS; MOTOR NEURON DISEASE;

EID: 84877665543     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2013-000557     Document Type: Review

References (73)

1. Davies Z, Turner MR. Public awareness of motor neuron disease. Amyotroph Lateral Scler 2010;11:490-491.
2. Matthews WB. Practical neurology. 2nd edn. Philadelphia: F.A. Davis Company, 1970.
3. Turner MR, Bowser R, Bruijn L, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. ALS and Frontotemporal Degeneration. 2013;14 (suppl 1): 19-32.
4. Mitchell JD, Callagher P, Gardham J, et al. Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)-a 20-year review: Can we do better? Amyotroph Lateral Scler 2010;11:537-541.
5. Kiernan MC, Vucic S, Cheah BC, et al. Amyotrophic lateral sclerosis. Lancet 2011;377:942-955.
6. Turner MR, Al-Chalabi A. No paradox. BMJ 2002. http://www.bmj.com/rapid-response/2011/10/29/no-paradox (accessed 20 Feb 2013)
7. Mott F. A case of amyotrophic lateral sclerosis with degeneration of the motor path from the cortex to the periphery. Brain 1895;18:21-36.
8. Turner MR, Brockington A, Scaber J, et al. Pattern of spread and prognosis in lower limb-onset ALS. Amyotroph Lateral Scler 2010;11:369-373.
9. Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 2009;73:805-811.
10. Turner MR. Increased premorbid physical activity and amyotrophic lateral sclerosis. Born to run rather than run to death, or a seductive myth? J Neurol Neurosurg Psychiatry. Published Online First: 27 February 2013 doi:10.1136/jnnp-2013-304935
11. Grossman AB, Levin BE, Bradley WG. Premorbid personality characteristics of patients with ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2006;7:27-31.
12. Turner MR, Parton MJ, Shaw CE, et al. Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002. J Neurol Neurosurg Psychiatry 2003;74:995-997.
13. Brownell B, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neuro surg Psychiatry 1970;33:338-357.
14. Pringle CE, Hudson AJ, Munoz DG, et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992;115(Pt 2):495-520.
15. Chio A, Calvo A, Moglia C, et al. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011;82:740-746.
16. Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 2012;83:102-108.
17. Logroscino G, Traynor BJ, Hardiman O, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008;79:6-11.
18. Simon NG, Kiernan MC. Fasciculation anxiety syndrome in clinicians. J Neurol 2013 (ePub ahead of print).
19. Chen Z, Turner MR. The internet for self-diagnosis and prognostication in ALS. Amyotroph Lateral Scler 2011;11:565-567.
20. Becker KL. Neuromuscular manifestations of endocrine disease. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott, Williams & Wilkins, 2001:1914.
21. Mills KR. Characteristics of fasciculations in amyotrophic lateral sclerosis and the benign fasciculation syndrome. Brain 2011;133:3458-3469.
22. de Carvalho M, Swash M. Fasciculation potentials and earliest changes in motor unit physiology in ALS. J Neurol Neurosurg Psychiatry. Published Online First: 16 February 2013 doi:10.1136/jnnp-2012-304545
23. Douglass CP, Kandler RH, Shaw PJ, et al. An evaluation of neurophysiological criteria used in the diagnosis of motor neuron disease. J Neurol Neurosurg Psychiatry 2010;81:646-649.
24. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 1993;116(Pt 2):453-469.
25. Vlam L, van der Pol WL, Cats EA, et al. Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies. Nat Rev Neurol 2013;8:48-58.
26. Parsonage MJ, Turner JW. Neuralgic amyotrophy; the shoulder-girdle syndrome. Lancet 1948;1:973-978.
27. van Alfen N. Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol 2011;7:315-322.
28. Tsao BE, Ostrovskiy DA, Wilbourn AJ, et al. Phrenic neuropathy due to neuralgic amyotrophy. Neurology 2006;66:1582-1584.
29. Kennedy WR, Alter M, Sung JH. Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 1968;18:671-680.
30. Rhodes LE, Freeman BK, Auh S, et al. Clinical features of spinal and bulbar muscular atrophy. Brain 2009;132:3242-3251.
31. Kimura A, Sakurai T, Koumura A, et al. Motor-dominant chronic inflammatory demyelinating polyneuropathy. J Neurol 2010;257:621-629.
32. Donaghy M, Mills KR, Boniface SJ, et al. Pure motor demyelinating neuropathy: deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994;57:778-783.
33. Sabatelli M, Madia F, Mignogna T, et al. Pure motor chronic inflammatory demyelinating polyneuropathy. J Neurol 2001;248:772-777.
34. Lotz BP, Engel AG, Nishino H, et al. Inclusion body myositis. Observations in 40 patients. Brain 1989;112(Pt 3):727-747.
35. Sayers ME, Chou SM, Calabrese LH. Inclusion body myositis: analysis of 32 cases. J Rheumatol 1992;19:1385-1389.
36. Koppers M, van Blitterswijk MM, Vlam L, et al. VCP mutations in familial and sporadic amyotrophic lateral sclerosis. Neurobiol Aging 2012;33:837+e7-e13.
37. Hirayama K, Tsubaki T, Toyokura Y, et al. Juvenile muscular atrophy of unilateral upper extremity. Neurology 1963;13:373-380.
38. Gourie-Devi M, Nalini A. Long-term follow-up of 44 patients with brachial monomelic amyotrophy. Acta Neurol Scand 2003;107:215-220.
39. Hu MT, Ellis CM, Al Chalabi A, et al. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1998;65:950-951.
40. Deluca GC, Boes CJ, Krueger BR, et al. Ventral intraspinal fluid-filled collection secondary to CSF leak presenting as bibrachial amyotrophy. Neurology 2011;76:1439-1440.
41. Bowen J, Gregory R, Squier M, et al. The post-irradiation lower motor neuron syndrome neuronopathy or radiculopathy? Brain 1996;119(Pt 5):1429-1439.
42. Moulignier A, Moulonguet A, Pialoux G, et al. Reversible ALS-like disorder in HIV infection. Neurology 2001;57:995-1001.
43. Centner CM, Bateman KJ, Heckmann JM. Manifestations of HIV infection in the peripheral nervous system. Lancet Neurol 2013;12:295-309.
44. Vucic S, Tian D, Chong PS, et al. Facial onset sensory and motor neuronopathy (FOSMN syndrome): a novel syndrome in neurology. Brain 2006;129:3384-3390.
45. Depienne C, Stevanin G, Brice A, et al. Hereditary spastic paraplegias: an update. Curr Opin Neurol 2007;20:674-680.
46. Antel J, Antel S, Caramanos Z, et al. Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol 2012;123:627-638.
47. Apostolski S, Nikolic J, Bugarski-Prokopljevic C, et al. Serum and CSF immunological findings in ALS. Acta Neurol Scand 1991;83:96-98.
48. Pal S, Malhotra RM, Davenport RJ, et al. Progressive unsteadiness in a 68-year-old man with longstanding abdominal pain and altered bowel habit. Pract Neurol 2009;9:210-220.
49. Turner MR, Talbot K. Functional vitamin B12 deficiency. Pract Neurol 2009;9:37-341.
50. Engelen M, Kemp S, de Visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 2012;7:51.
51. Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80:496-503.
52. Kano O, Iwamoto K, Ito H, et al. Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset. BMC Neurol 2013;13:19.
53. Wijesekera LC, Mathers S, Talman P, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009;72:1087-1094.
54. Turner MR, Scaber J, Goodfellow JA, et al. The diagnostic pathway and prognosis in bulbar-onset amyotrophic lateral sclerosis. J Neurol Sci 2010;294:81-85.
55. Burrell JR, Vucic S, Kiernan MC. Isolated bulbar phenotype of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2011;12:283-289.
56. Shoesmith CL, Findlater K, Rowe A, et al. Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry 2007;78:629-631.
57. Turner MR, Lawrence H, Arnold I, et al. Catastrophic hyperkalaemia following administration of suxamethonium chloride to a patient with undiagnosed amyotrophic lateral sclerosis. Clin Med 2011;11:292-293.
58. Snowden JS, Rollinson S, Thompson JC, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012;135:693-708.
59. Turner MR, Barnwell J, Al-Chalabi A, et al. Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain 2012;135:2883-2891.
60. Baumer D, Hilton D, Paine SM, et al. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 2010;75:611-618.
61. Isaacs JD, Shaw CE, Al-Chalabi A, et al. Extending the phenotype of ALS: Whither the sensory nerves? J Neurol Neurosurg Psychiatry 2006;77:137.
62. Chio A, Canosa A, Gallo S, et al. Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol 2012;19:551-555.
63. Hudson AJ. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. Brain 1981;104:217-247.
64. Sharma R, Hicks S, Berna CM, et al. Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review. Arch Neurol 2011;68:857-861.
65. Turner MR, Gerhard A, Al-Chalabi A, et al. Mills' and other isolated upper motor neuron syndromes: In vivo study with [11C]-PK11195 PET. J Neurol Neurosurg Psychiatry 2005;76:871-874.
66. Turner MR, Chohan G, Quaghebeur G, et al. A case of celiac disease mimicking amyotrophic lateral sclerosis. Nat Clin Pract Neurol 2007;3:581-4.
67. Turner MR, Talbot K. Motor neurone disease is a clinical diagnosis. Pract Neurol 2012;12:396-397.
68. Younger DS, Rowland LP, Latov N, et al. Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis. Ann Neurol 1991;29:78-86.
69. Forsyth PA, Dalmau J, Graus F, et al. Motor neuron syndromes in cancer patients. Ann Neurol 1997;41:722-730.
70. Qureshi M, Bedlack RS, Cudkowicz ME. Lyme disease serology in amyotrophic lateral sclerosis. Muscle Nerve 2009;40:626-628.
71. Echaniz-Laguna A, Dietemann JL. Neurological picture. Seeing the blocks: MRI of the brachial plexus in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 2011;82:728.
72. Slee M, Selvan A, Donaghy M. Multifocal motor neuropathy: the diagnostic spectrum and response to treatment. Neurology 2007;69:1680-1687.
73. Eisen A, Kuwabara S. The split hand syndrome in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2012;83:399-403.